UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a ...

A weekly diabetes medication may replace painful daily hormone injections for patients with congenital generalised lipodystrophy (CGL). Early findings suggest that tirzepatide – used for diabetes and ...

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

The 50 mg oral semaglutide pill achieved a 15.1% ... The study – published in the New England Journal of Medicine – revealed a 14.7% reduction in body weight with orforglipron in patients ...

It is thought that neither semaglutide nor tirzepatide are ... The results have been published in the New England Journal of Medicine. Professors Wassilios Meissner and Olivier Rascol of Toulouse ...

Zepbound® (tirzepatide) provided a 47% greater relative weight loss compared to Wegovy® (semaglutide ... results were published in The New England Journal of Medicine simultaneously with ...

Eli Lilly's weight-loss jab Mounjaro has been cleared for rollout by the NHS in England, with around 3.4 ... real concerns that the prices of the new generation of so-called 'incretin' obesity ...

1 Section of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT 2 Department of Health Policy and Management, Yale School of Public Health ...

New England Business Media ... a daily update of the area’s most important business news. Worcester Business Journal provides the top coverage of news, trends, data, politics and personalities ...

The development of simple, reliable ultraviolet and visible spectrophotometers within the last ten years has made available an analytical tool of great versatility and power. The role played by ...

Ben Fischer of Sports Business Journal recently explained that the league has kept ... And same thing when we got good at Cleveland and then at New England. I mean, it’s [Tom] Brady, it’s [Willie] ...